Search for: "GlaxoSmithKline LLC"
Results 161 - 179
of 179
Sorted by Relevance
|
Sort by Date
21 Jul 2023, 11:56 am
GlaxoSmithKline, 905 F.3d 694, 707 (3d Cir. 2018) that such an inquiry is fact-specific and requires the consideration of multiple factors. [read post]
19 Oct 2009, 1:24 am
The ruling wipes out verdicts of $33 million against Novartis, $81 million against GlaxoSmithKline, and $215 million (reduced post-trial to $160 million) against AstraZeneca. [read post]
24 Aug 2021, 2:10 am
Teva GlaxoSmithKline LLC v. [read post]
4 Nov 2021, 7:03 pm
The health care industry is no longer limited to doctors and hospitals, but a veritable thicket of holding companies, LLCs, and private equity firms. [read post]
26 Sep 2022, 4:49 am
GlaxoSmithKline LLC, No. 22-37 This case delves deeply into the patent-FDA overlap and involves an increasingly common situation “skinny label” situation. [read post]
11 Jan 2008, 9:00 am
., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz that use of Markush group language in the specification does not necessarily limit construction of claim terms: (Chicago IP Litigation),Coreg / Dilatrend / Eucardic (Carvedilol) - Teva Pharmaceutical… [read post]
10 Mar 2014, 11:31 am
Here’s another “little list” that came about because of Bexis updating chapter two (information-based claims) of his book. [read post]
3 Apr 2009, 1:05 am
The opinion follows a similar recent 5th Circuit ruling in which the court upheld summary judgment for Paxil maker GlaxoSmithKline on learned intermediary grounds. [read post]
1 Oct 2010, 9:26 am
GlaxoSmithKline, PLC, 2010 WL 3527601 (E.D. [read post]
4 Jan 2017, 7:09 pm
The defendant, GlaxoSmithKline LLC (GSK), invoking Federal Rule of Evidence 702, moved to exclude opinion testimony of several of plaintiffs’ expert witnesses, including Laura M. [read post]
18 May 2023, 8:01 am
GlaxoSmithKline LLC, involving an undoubtedly important and recurring issue involving drug labeling and inducement of patent infringement. [read post]
3 Aug 2009, 6:18 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
1 Feb 2013, 9:42 am
GlaxoSmithKline, PLC, 737 F. [read post]
1 Oct 2009, 2:14 am
GlaxoSmithKline PLC, 2008 WL 2247067 (E.D. [read post]
1 Jun 2010, 8:16 am
Alcatel-Lucent, sustained District Court judgement of validity and infringement by Microsoft of Alcatel-Lucent’s patent, Summer 2009 GlaxoSmithKline v. [read post]
25 Jan 2010, 5:00 am
S & M NuTec LLC, 245 F.R.D. 429, 438 (C.D. [read post]
30 May 2008, 9:09 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and de-branding of… [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) –… [read post]
